FDA Inspection 1304230 — Courtney R. Goodwin, M.D., Ph.D.
The FDA completed an inspection of Courtney R. Goodwin, M.D., Ph.D. on Feb 13, 2026 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional details
Clinical Investigator (CI)